Are you Dr. Lyons?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Dr. Timothy Lyons, MD is an endocrinologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina and Oklahoma.
Education & Training
Medical University of South CarolinaResidency, Internal Medicine, 1984 - 1986
Queen's University Belfast Faculty of MedicineClass of 1977
Certifications & Licensure
OK State Medical License 2002 - 2025
SC State Medical License 1991 - 2025
Clinical Trials
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Start of enrollment: 2016 Nov 03
Publications & Presentations
PubMed
- Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.Andrzej S Januszewski, Hayden K Young, Kwok-Leung Ong, Liping Li, Rachel L O'Connell
Journal of Diabetes Investigation. 2024-11-01 - Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy.Yi Lei, Qiangyun Liu, Binggui Chen, Fangfang Wu, Yiming Li
Nature Communications. 2024-10-29 - 1 citationsRelaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status.Aidan Anderson, Nada Alfahad, Dulani Wimalachandra, Kaouthar Bouzinab, Paula Rudzinska
Nature Communications. 2024-02-06
Grant Support
- Early Markers Of Pre-Eclampsia In Native American With Type 2 DiabetesNational Center On Minority Health And Health Disparities2007–2011
- Lipoproteins And PEDF In The Vascular Complications Of DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Effects Of Chronic Green TEA Flavonoid Supplementation On Biomarkers Of OxidatiNational Center For Research Resources2007
- Markers And Mechanisms Of Vascular Disease In DiabetesNational Center For Research Resources2005–2007
- Apolipoprotein-Based Lipoprotein Subclass Profiles &Vasc Complic Of DiabetesNational Center For Research Resources2005–2007
- Markers &Mechanisms For Pre-Eclampsia In Women W/Type 1 DiabetesNational Center For Research Resources2004–2007
- Markers Amp;Mechanisms For Pre-Eclampsia In Women W/Type 1 DiabetesNational Center For Research Resources2006
- Apolipoprotein-Based Lipoprotein Subclass Profiles Amp;Vasc Complic Of DiabetesNational Center For Research Resources2006
- Apolipoproteins And The Complications Of Type 1 DiabetesNational Heart, Lung, And Blood Institute2004–2005
- Lipoproteins And Oxidative StressNational Heart, Lung, And Blood Institute2001–2005
- Epidemiology Of Diabetes Intervention &ComplicationsNational Center For Research Resources2001–2002
- Glycoxidation And Diabetic RetinopathyNational Center For Research Resources1997–2002
- Glycoxidation And Macrovascular Disease In DiabetesNational Heart, Lung, And Blood Institute1996–2000
- Glycoxidation And Macrovascular Disease In IDDMNational Center For Research Resources1998–1999
- Glycoxidation And Diabetic RetinopathyNational Eye Institute1994–1998
